Increased intracellular formation of advanced glycation end-products
AGEs are found in increased amounts in diabetic retinal vessels
20
and
renal glomeruli
21
. They were originally thought to arise from non-
enzymatic reactions between extracellular proteins and glucose. But
the rate of AGE formation from glucose is orders of magnitude slow-
er than the rate of AGE formation from glucose-derived dicarbonyl
precursors generated intracellularly, and it now seems likely that
intracellular hyperglycaemia is the primary initiating event in the
formation of both intracellular and extracellular AGEs
22
. AGEs can
arise from intracellular auto-oxidation of glucose to glyoxal
23
,
decomposition of the Amadori product (glucose-derived 1-amino-
1-deoxyfructose lysine adducts) to 3-deoxyglucosone (perhaps
accelerated by an amadoriase), and fragmentation of glyceraldehyde-
3-phosphate and dihydroxyacetone phosphate to methylglyoxal
24
.
These reactive intracellular dicarbonyls — glyoxal, methylglyoxal
and 3-deoxyglucosone — react with amino groups of intracellular
and extracellular proteins to form AGEs. Methylglyoxal and glyoxal
are detoxified by the glyoxalase system
24
. All three AGE precursors are
also substrates for other reductases
25
.
The potential importance of AGEs in the pathogenesis of diabetic
complications is indicated by the observation in animal models that
two structurally unrelated AGE inhibitors partially prevented
various functional and structural manifestations of diabetic
microvascular disease in retina, kidney and nerve
26–28
. In a large
randomized, double-blind, placebo-controlled, multi-centre trial in
type 1 diabetic patients with overt nephropathy, the AGE inhibitor
aminoguanidine lowered total urinary protein and slowed progres-
sion of nephropathy, over and above the effects of existing optimal
care. In addition, aminoguanidine reduced the progression of
diabetic retinopathy (K. K. Bolton et al., submitted).
Production of intracellular AGE precursors damages target cells
by three general mechanisms (Fig. 2). First, intracellular proteins
modified by AGEs have altered function. Second, extracellular
matrix components modified by AGE precursors interact abnormal-
ly with other matrix components and with the receptors for matrix
proteins (integrins) on cells. Third, plasma proteins modified by
AGE precursors bind to AGE receptors on endothelial cells, mesan-
gial cells and macrophages, inducing receptor-mediated production
of reactive oxygen species. This AGE receptor ligation activates the
pleiotropic transcription factor NF-
kB, causing pathological
changes in gene expression.
In endothelial cells exposed to high glucose, intracellular AGE
formation occurs within a week. Basic fibroblast growth factor is one
Chia sẻ với bạn bè của bạn: |